Second cancer risk following Hodgkin's disease : a 20-year follow-up study.
To determine risk factors for the development of second primary cancers during long-term follow-up of patients with Hodgkin's disease (HD).
Patients and Methods
We assessed the risk of second cancers (SCs) in 1939 HD patients, who were admitted to the Netherlands Cancer Institute (NKI; Amsterdam) or the Dr Daniel den Hoed Cancer Center (DDHK; Rotterdam) between 1966 and 1986.
For 97% of the cohort, we obtained a medical status up to at least January 1989, the median follow-up duration of the patients was 9.2 years; for 17% of the patients, follow-up was longer than 15years.
For more than 98% of all second tumors, the diagnosis was confirmed through a pathology report.
Mots-clés Pascal : Hodgkin maladie, Facteur risque, Etude longitudinale, Second cancer, Epidémiologie, Pays Bas, Europe, Homme, Lymphome, Lymphoprolifératif syndrome, Hémopathie maligne, Tumeur maligne
Mots-clés Pascal anglais : Hodgkin disease, Risk factor, Follow up study, Second cancer, Epidemiology, Netherlands, Europe, Human, Lymphoma, Lymphoproliferative syndrome, Malignant hemopathy, Malignant tumor
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0294743
Code Inist : 002B19B. Création : 199406.